Literature DB >> 8133903

Distribution and characterisation of [3H]alpha,beta-methylene ATP binding sites in the rat.

A D Michel1, P P Humphrey.   

Abstract

Radioligand binding studies have been performed to study the distribution of the binding sites for the P2x purinoceptor selective agonist radioligand, [3H]alpha,beta-methylene ATP ([3H]alpha beta-meATP), in membranes prepared from various peripheral organs and several brain regions of the rat. In agreement with previous studies in the rat vas deferens, [3H]alpha beta-meATP labelled two populations of sites. One site exhibited high affinity for the ligand (Kd = 0.7 nM; Bmax = 1012 fmol.mg-1 protein) while the other site exhibited lower affinity (Kd = 70.8 nM) and higher capacity (Bmax) = 7470 fmol.mg-1 protein). In competition studies, using a low concentration of radioligand (1 nM), the high affinity alpha beta-meATP binding sites in vas deferens membranes could be preferentially labelled (84-91%). Under these conditions, the P2x purinoceptor agonists, alpha beta-meATP and beta, gamma-methylene ATP, had the highest affinity with pIC50 values of 8.3 and 7.3 respectively. The P2y purinoceptor agonist, 2-methyl-thio-ATP (2-me-S-ATP), had lower affinity (pIC50 = 6.7), while uridine triphosphate, adenosine diphosphate and adenosine, agonists at the P2u, P2t and P1 purinoceptors, respectively, possessed low affinity (pIC50 values < 5.6). In addition, the P2 purinoceptor antagonists, cibacron blue and suramin, inhibited binding over the same concentration range at which they behave as functional antagonists at the P2x purinoceptor. High and low affinity binding sites for [3H]alpha beta-meATP were also identified in a range of other peripheral tissues (spleen, heart and liver) and in several brain regions (striatum, cerebral cortex, hippocampus). In the spleen, heart, cerebral cortex and liver the Kd values at both the high affinity binding sites (Kd = 1-1.2 nM) and the low affinity binding sites (Kd = 98-158 nM) were similar to the respective Kd values at the high and low affinity binding sites in the vas deferens. In competition studies performed using a low concentration of radioligand (1 nM) these sites exhibited a similar pharmacological profile to that seen in the vas deferens. Detailed analysis of competition curves to several of the ATP analogues in each of the tissues revealed that the binding profile of the radioligand was complex since several compounds, and in particular ATP and 2-me-S-ATP, identified a lower proportion of sites with high affinity than did alpha beta-meATP.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8133903     DOI: 10.1007/bf00167237

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  A novel receptor-operated Ca2+-permeable channel activated by ATP in smooth muscle.

Authors:  C D Benham; R W Tsien
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

Review 2.  Biochemical properties of a P2Y-purinergic receptor.

Authors:  T K Harden; J L Boyer; H A Brown; C L Cooper; R A Jeffs; M W Martin
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

3.  Kinetics and mechanism of L-[3H]nicotine binding to putative high affinity receptor sites in rat brain.

Authors:  P M Lippiello; S B Sears; K G Fernandes
Journal:  Mol Pharmacol       Date:  1987-04       Impact factor: 4.436

4.  High- and low-affinity binding sites for [3H]-alpha, beta-methylene ATP in rat urinary bladder membranes.

Authors:  X N Bo; G Burnstock
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

Review 5.  Signal transduction by P2-purinergic receptors for extracellular ATP.

Authors:  G R Dubyak
Journal:  Am J Respir Cell Mol Biol       Date:  1991-04       Impact factor: 6.914

6.  Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli.

Authors:  C H Hoyle; G E Knight; G Burnstock
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

7.  Guanine nucleotide-sensitive interaction of a radiolabeled agonist with a phospholipase C-linked P2y-purinergic receptor.

Authors:  C L Cooper; A J Morris; T K Harden
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

Review 8.  Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides.

Authors:  R Seifert; G Schultz
Journal:  Trends Pharmacol Sci       Date:  1989-09       Impact factor: 14.819

9.  Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery.

Authors:  I von Kügelgen; D Häussinger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

10.  Excitatory effects of adenosine 5'-triphosphate on rat locus coeruleus neurones.

Authors:  M Tschöpl; L Harms; W Nörenberg; P Illes
Journal:  Eur J Pharmacol       Date:  1992-03-17       Impact factor: 4.432

View more
  18 in total

1.  Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry.

Authors:  L Vulchanova; U Arvidsson; M Riedl; J Wang; G Buell; A Surprenant; R A North; R Elde
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

Review 2.  New insights on P2X purinoceptors.

Authors:  P P Humphrey; G Buell; I Kennedy; B S Khakh; A D Michel; A Surprenant; D J Trezise
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

3.  P2-Purinoceptors: Advances and therapeutic opportunities.

Authors:  Michael Williams; Kenneth A Jacobson
Journal:  Expert Opin Investig Drugs       Date:  1995-10       Impact factor: 6.206

4.  The binding characteristics of a human bladder recombinant P2X purinoceptor, labelled with [3H]-alpha beta meATP, [35S]-ATP gamma S or [33P]-ATP.

Authors:  A D Michel; K Lundström; G N Buell; A Surprenant; S Valera; P P Humphrey
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

5.  The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate.

Authors:  D J Trezise; I Kennedy; P P Humphrey
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors.

Authors:  A D Michel; K Lundström; G N Buell; A Surprenant; S Valera; P P Humphrey
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  High affinity P2x-purinoceptor binding sites for [35S]-adenosine 5'-O-[3-thiotriphosphate] in rat vas deferens membranes.

Authors:  A D Michel; P P Humphrey
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

8.  Effects of metal cations on [3H]alpha,beta-methylene ATP binding in rat vas deferens.

Authors:  A D Michel; P P Humphrey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

9.  Evidence for the presence of both pre- and postjunctional P2-purinoceptor subtypes in human isolated urinary bladder.

Authors:  S Palea; C Pietra; D G Trist; W Artibani; A Calpista; M Corsi
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  Purinergic receptors in the splanchnic circulation.

Authors:  Manuela Morato; Teresa Sousa; António Albino-Teixeira
Journal:  Purinergic Signal       Date:  2008-04-29       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.